Oculis Holding AG (OCS) Share-based Compensation (2022 - 2026)
Oculis Holding AG's Share-based Compensation came in at $8.4 million for Q2 2026, up 53.3% from $5.48 million a year earlier and up 31.6% from the prior quarter.
Powered by 
Analysis
Oculis Holding AG (OCS) Share-based Compensation (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Oculis Holding AG reported Share-based Compensation of $25.89 million, up 78.1% year-over-year; for FY2025, it came in at $20.07 million, up 80.5% from FY2024.
- Share-based Compensation has increased in each of the last five years, with a five-year compound annual growth rate of 124.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $11.12 million in FY2024 (+173.4%), $4.07 million in FY2023 (+382.6%), $842,820 in FY2022 (+134.8%) and $358,946 in FY2021 (+2.6%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q3 2022.
- Year-over-year, Share-based Compensation has increased for 12 consecutive quarters, with growth averaging 99.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Share-based Compensation ran from 50.3% in Q2 2025 to 733.9% in Q1 2024.
- Business Quant data shows OCS's Share-based Compensation at $6.39 million (Q1 2026), $5.4 million (Q4 2025) and $5.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Oculis Holding AG | 473.32 Mn | 473.32 Mn | - | 8.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.40 Mn |
| Mar 31, 2026 | 6.39 Mn |
| Dec 31, 2025 | 5.40 Mn |
| Sep 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.48 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 156,768.57 |
| Dec 31, 2022 | 150,513.18 |
| Sep 30, 2022 | 200,878.59 |
API Access
Oculis Holding AG Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OCS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();